DRCongo approves use of five new Ebola drugs — WHO
Punchng.com
June 7, 2018
The Democratic Republic of the Congo has approved the use of five investigational therapeutics to treat Ebola Virus Disease, marking the first time such treatments would be available in the midst of an Ebola outbreak in the country, the WHO said.
WHO said four of the five approved drugs are currently in the country, which are Zmapp, GS-5734, REGN monoclonal antibody combination, and mAb114, under the framework of compassionate use and expanded access.
Clinicians working in the treatment centres will make decisions on which drug to use as deemed helpful for their patients, and appropriate for the setting.
The treatments can be used as long as informed consent is obtained from patients and protocols are followed, with close monitoring and reporting of any adverse events.
Earlier in May, WHO convened a group of independent scientific experts to evaluate investigational therapeutics for EVD during the current outbreak in the DRC.
The Rest…HERE
